Home › Funds › TCG Crossover Management, LLC › ABVX
TCG Crossover Management, LLC position in ABVX
ABIVAX SA · Health Care
TCG Crossover Management, LLC reported holding 3,663,038 shares of ABVX (ABIVAX SA) in its Q3 2026 13F filing — a position valued at US$362.7M, representing 10.25% of its reported portfolio and ranking #1 among its reported holdings. TCG Crossover Management, LLC has disclosed ABVX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How TCG Crossover Management, LLC's ABVX position evolved
TCG Crossover Management, LLC first disclosed a stake in ABVX in Q4 2023 at 1,100,000 shares (US$11.8M). The position peaked in Q4 2025 at 7,111,596 shares, worth US$959.0M. Across 12 filings, TCG Crossover Management, LLC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 3,663,038 shares valued at US$362.7M — a reduction of -2,344,796 shares quarter over quarter.. Notable position changes include a 451% increase in Q2 2024 (shares fell 13% over the following quarter), a 39% trim in Q3 2026 (shares fell 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 1.10M | $11.77M | New |
| Q1 2024 | 1.10M | $15.73M | Hold |
| Q2 2024 | 6.06M | $80.07M | Add |
| Q3 2024 | 6.06M | $69.77M | Hold |
| Q4 2024 | 6.06M | $44.33M | Hold |
| Q1 2025 | 6.06M | $37.85M | Hold |
| Q2 2025 | 6.06M | $46.33M | Hold |
| Q3 2025 | 7.11M | $603.77M | Add |
| Q4 2025 | 7.11M | $959.03M | Hold |
| Q1 2026 | 6.48M | $721.67M | Reduce |
| Q2 2026 | 6.01M | $800.60M | Reduce |
| Q3 2026 | 3.66M | $362.71M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABVX and 13F data
ABVX (ABIVAX SA) is a Health Care company. 65 other funds we track also report a position in ABVX — the largest reported positions include Helikon Investments Ltd (US$418.2M), Darwin Global Management, Ltd. (US$348.2M), Vestal Point Capital, LP (US$313.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- Helikon Investments Ltd 4.22M sh · $418.15M · Q3 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- Caligan Partners LP 1.56M sh · $207.61M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.65M sh · $163.56M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Octagon Capital Advisors LP 993.00K sh · $132.33M · Q2 2026
- Eversept Partners, LP 1.10M sh · $108.99M · Q3 2026
- Cormorant Asset Management, LP 675.00K sh · $89.95M · Q2 2026
- Logos Global Management LP 870.00K sh · $86.15M · Q3 2026
- Boxer Capital Management, LLC 605.00K sh · $80.62M · Q2 2026
- Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. 762.82K sh · $75.53M · Q3 2026
More on TCG Crossover Management, LLC
FAQ
How long has TCG Crossover Management, LLC held ABVX?
TCG Crossover Management, LLC has disclosed ABVX holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is TCG Crossover Management, LLC's current position in ABVX?
As of Q3 2026, TCG Crossover Management, LLC holds 3.66M shares of ABVX (ABIVAX SA), valued at $362.71M, representing 10.25% of its reported portfolio and ranking #1.
Has TCG Crossover Management, LLC been buying or selling ABVX?
In the latest 13F filing (Q3 2026), TCG Crossover Management, LLC reduced its position in ABVX. The position peaked in Q4 2025 at 7.11M shares.
Which other funds hold ABVX?
Other major institutional holders of ABVX include Helikon Investments Ltd, Darwin Global Management, Ltd., Vestal Point Capital, LP, among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.